This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Ultromics has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), along with Pfizer and AstraZeneca, for its EchoGo Amyloidosis software. EchoGo Amyloidosis is an AI screening tool that detects amyloidosis from a single echocardiography clip. The device is the first of the 55 devices enrolled in the FDA’s Total Product Life Cycle Advisory Program (TAP) to secure marketing authorization, Ultromics said.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
Royal Philips will unveil its 1.5-tesla BlueSeal MR wide-bore scanner at RSNA 2024 in Chicago, IL. The scanner features a 70 cm design and integrated AI-enabled MR Smart Workflow software, the latter of which increases patient throughput without compromising diagnostic quality, the company said. Philips added that the scanner's performance will be boosted by its Smart Reading technology, which consists of components such as the following: SmartExam for automated MRI exam planning, scanning, and
tim.hodson Thu, 11/21/2024 - 15:10 Nov. 21, 2024 — Royal Philips plans to unveil its next-generation 1.5T BlueSeal MR wide-bore scanner at RSNA 2024 in Chicago, Dec. 1-4. The latest generation scanner features a 70 cm wide-bore design and integrates AI-enabled MR Smart Workflow solutions, designed to enhance access and diagnostic confidence to improve outcomes for more patients.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Large language models (LLMs) demonstrate high accuracy on radiology exams, yet decrease in accuracy over time, according to research published November 20 in the European Journal of Radiology. The study provides a foundational benchmark for future LLM performance evaluations in the field, noted lead author Mitul Gupta, a medical student at the University of Texas at Austin, and colleagues.
Frequent AI use is associated with an increased risk of radiologist burnout, particularly among those with high workloads and low AI acceptance, suggests a study published November 22 in JAMA Network Open. The finding is based on a nationwide survey in China, and although more research is needed to explore the issue, the study highlights the urgent need to prioritize coordination strategies between radiologists and AI tools, noted lead author Hui Liu, PhD, of the Chinese Academy of Medical Scien
tim.hodson Thu, 11/21/2024 - 14:43 Nov. 20, 2024 — Bracco Diagnostics Inc. and ColoWatch have announced a new partnership to deliver a turnkey solution for imaging facilities to expand the availability of colorectal cancer (CRC) screening tests using virtual colonoscopy. Co-founder and Chief Medical Officer at ColoWatch, Dr. Mark Klein said, "With the increased risk of colorectal cancer in younger patients and evidence that screening saves lives, the time to expand access to virtual colonoscopy
Shear-wave elastography shows tissue stiffness in athletes with low-back pain, according to research published November 22 in the Archives of Physical Medicine and Rehabilitation. A team led by Siu Ngor Fu, PhD, from the Hong Kong Polytechnic University found higher deep lumbar multifidus (DLM) stiffness in athletes with low-back pain and higher superficial lumbar multifidus (SLM) stiffness in athletes involved in sports with greater demands on back extension.
The UK government’s recent budget announcement delivered an unexpected and much-needed boost for the NHS, with an additional £25.7 billion allocated over the next two years. Notably, this increase spans both operational and capital expenditure, aiming to address immediate needs while also investing in the long-term sustainability of healthcare services.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Apollo Radiology International (ARI), an India-based unit of the specialized radiology venture Apollo Group in Asia, has acquired the radiology reporting wing of InHealth Group in the U.K. ARI said the acquisition addresses the shortage of radiologists worldwide and strengthens its teleradiology footprint globally, adding that it projects to report over 2 million scans annually covering 24 countries for more than 200 healthcare organizations.
In the world of startups, getting the right talent on board is mission critical. You need to have the right team to get that early momentum and ultimate success. The challenge is, in a fast-paced environment, companies struggle to distill their vision in a way that connects with people outside of the organization. On top of that, in those early stages, it’s hard to dig for the intangible skills your company needs, and create a value proposition that attracts the talent you want.
The RSNA has named the winners of its 2024 Lumbar Spine Degenerative Classification AI Challenge. The challenge explored whether AI can be used to aid in the detection and classification of degenerative spine conditions using lumbar spine MR images. The curated and annotated dataset, developed in collaboration with the American Society of Neuroradiology (ASNR), included images from eight sites across five continents.
Researchers have uncovered how different types of brain cells work together to form large-scale functional networks in the human brain -- interconnected systems that support everything from sensory processing to complex decision-making -- paving the way for new insights into brain health and disease.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Cortechs.ai , an AI developer focused on neuroimaging and prostate imaging, has closed an oversubscribed Series C funding round led by Vilas Ventures. The funds will be used to further advance the company's technological offerings and expand its product suite and market reach. Existing investor Genting Berhad, a global conglomerate, also participated in the round.
Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
Healthcare's adoption of off-site cloud storage streamlines IT operations, improves collaboration, enhances security, and prioritises patients. The post The Cloud Revolution: Transforming Healthcare Through Off-Site Data Storage appeared first on Open MedScience.
Offering a variety of AI-enabled tools to facilitate radiology workflow efficiency, the BlueSeal MRI system is reportedly the first wide bore, helium-free 1.5T MRI platform in the field.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Microwave ablation (MWA) is a minimally invasive technique that destroys tumor tissue through thermal necrosis. Most adverse events of MWA are localized, including liver abscess formation or injury to surrounding visceral, vascular, or biliary structures (1).
Digital twins, bridging physical and virtual world, enable real-time simulations, improving healthcare, engineering, urban planning, and innovative research. The post The Power of Digital Twins: Simulating the Real World for Better Insights appeared first on Open MedScience.
Attrition in graduate medical education poses challenges to both the trainees and the programs. Leaving their current residency may allow residents to choose a career more suited to them but may also result in lost time and a personal sense of failure (1). Negative impacts on the programs include the loss of resources spent on resident onboarding and training, increased workload for remaining residents, and facing off-cycle recruitment challenges (1).
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Theranostics could be cited for speeding in this year’s Road to RSNA. It's only been a few years since a dedicated track in nuclear medicine and molecular imaging was established at the meeting, and the practice already dominates it. Theranostics is featured in dozens of studies in eight scientific sessions, as well as twice a day (10 out of 41 total) on the main stages of the Learning Center at McCormick Place.
Transcatheter retrograde testicular vein embolisation for symptomatic varicoceles is well-established but has a documented failure rate. Percutaneous anterograde varicocele embolisation may be a suitable alternative. A retrospective observational, descriptive study of consecutive patients who underwent percutaneous anterograde varicocele embolisation at a single centre was performed.
A parent presents to the ED with their 6-week-old infant for evaluation of a fever. The infant was born full term and has no other symptoms. Physical exam is normal and vital signs are HR is 150 bpm, SpO2 is 99%, and a rectal T is 101.4°F (38.6°C). Blood cultures are sent and lab results from a CBC, procalcitonin, and urinalysis are as follows: WBC: 5,300/µL Hemoglobin: 12.2 g/dL Platelets: 205,000/µL Absolute neutrophil count: 2,600/µL Procalcitonin: 0.14 ng/mL Urinalysis WBC: 50–100/hpf RBC: 0
This study aims to test the hypothesis that Pressure Enabled Drug Delivery (PEDD) with a TriNav device would increase delivery of Embospheres via hepatic artery infusion to liver tumors in an oncopig model when compared to a conventional endhole microcatheter. Embospheres (100-300um in size) were fluorescently labeled and infused into porcine liver tumors using conventional technique (n=8) or by PEDD (n=8).
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
162 
Let's personalize your content